Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Norwegian Property ASA in connection with the sale of Norgani Hotels AS
Mandate

Vinge advises Norwegian Property ASA in connection with the sale of Norgani Hotels AS

November 08, 2010

Vinge has advised Norwegian Property ASA a company listed on the Oslo Stock Exchange in connection with the sale of Norgani Hotels AS to Sech Holding AB, a company owned by Pandox AB and Heches Holding AB, which, in turn, are controlled by Eiendomsspar AS and the Sundt family. Completion took place on 4 November and the purchase price amounted to approximately SEK 9.9 billion. Norgani Hotels AS conducts hotel ownership and management operations in the Nordic countries. The real estate portfolio consists of 73 hotels, 41 of which are located in Sweden. Following the acquisition, Pandox AB will be one of the leading hotel property owners in Europe with 119 hotels.

Vinge’s team consisted of partners Morgan Hallén and Fredrik Sonander and several associates including Christina Carrick.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025